SHEN H M,SHI C Y,SHEN Y,et al.Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1[J].Free Radical Biology and Medicine,1996,21(2):139-146.
[3]
KAMDEM L K,MEINEKE I,GODTEL-ARMBRUST U,et al.Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1[J].Chemical Research in Toxicology,2006,19:577-586.
[4]
RIFFEL A K,SCHUENEMANN E,VYHLIDAL C A,et al.Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family[J].MolPharmaco,2009,76(5):1104-1114.
[5]
YANO J K,WESTER M R,SCHOCH G A,et al.The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05A resolution[J].The Journal of Biological Chemistry,2004,279,(37):38091-38094.
[6]
HASHIMOTO H,TOIDE K,KITARMURA R,et al.Gene structure of CYP3A4 an adult specific form of cytochrome P450 in human livers,and its transcriptional control[J].European Journal of Biochemisty,1993;218:355-366.
LMBA J K,LIN Y S,SCHUETS E G,et al.Genetic contribution to variable human CYP3A-mediated metabolism[J].Advanced Drug Delivery Reviews,2002,54(10):1271-1294.
[9]
SATA F,SAPONE A,ELIZONDO G,et al.CYP3A4 allelic variants with amino acid substitutions in exon 7 and 12:evidence for an allelic variant with altered catalytic activity[J].Clinical Pharmacology & Therapeutics,2000,67:48-56.
AKIYAMA T E,GONZALEZ F J.Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors[J].Biochimica et Biophysica Acta (BBA):General Subjects,2003,1619(3):223-234.
[12]
DENISSENKO M F,CAHILL J,KOUDRIAKOVA B.Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems[J].Mutation Research,1999,425(2):205-211.
[13]
ATROSHI F,BIESE I,SALONIEMI H,et al.Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice[J].Canadian Society for Pharmaceutical Sciences,2000,3(3):281-291.
[14]
CHOI Y K,JUNG K K,CHAE K Y,et al.Effects of vitamin E and selenium supplementation to diets containing aflatoxin B1 on the contents of liver lipids and various blood parameters in rats[J].Australasian Journal of Animal Science,1995,8(4):379-385.
[15]
UENG Y F,SHIMADA T,YAMAZAKI H,et al.Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes[J].Chemical Research Toxicology,1996,8(2):218-225.
[16]
El-BAYOUMY K,SINHA R.Molecular chemoprevention by selenium:a genomic approach[J].Mutation Research,2005,591:224-236.
[17]
ALPSOY L,YALVAC M E.Key roles of vitamins A,C,and E in aflatoxin B1-induced oxidative stress[J].Vitamins & Hormones,2011,86:287-305.
[18]
REDDY L,ODHAV B,BHOOLA K,et al.Aflatoxin B1-induced toxicity in HepG2 cells inhibited by carotenoids:morphology,apoptosis and DNA damage[J].Biological Chemistry,2006,387(1):87-93.
[19]
SANG S,YANG I,BUCKLEY B,et al.Autoxidative quinine formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate:studied by real-time mass spectrometry combined with tandem mass ion mapping[J].Free Radical Biology & Medicine,2007,43:362-371.
[20]
HOU Z,SANG S M,YOU H,et al.Mechanism of action of (-)-epigallocatechin-3-gallate:auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells[J].Cancer Resesrch,2005,65:8049-8056.
